The Impact of Treatment Crossover and Prostate-specific Antigen Flare with Enzalutamide and Abiraterone in Metastatic Castrate Resistant Prostate Cancer

Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e92. doi: 10.1016/j.clon.2020.07.009. Epub 2020 Jul 29.

Authors

J McGrane¹, M Rowe¹, A Hidayat¹, S Walter², D Victor¹, T Norris³, A Pollard¹

Affiliations

¹ Sunrise Oncology Centre, Royal Cornwall Hospital, Truro, UK.
² Edinburgh Oncology Centre, Western General Hospital, Edinburgh, UK.
³ Exeter Oncology Centre, Royal Devon & Exeter Hospital, Exeter, UK.

PMID: 32739115
DOI: 10.1016/j.clon.2020.07.009

No abstract available

Publication types

Letter